RxDoctor Payments Data

Ahmed Mohamed

Cardiovascular Disease · Wichita, KSNPI 1720501588

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (49.4%), food and beverage and grants — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Abbott at 33.8% of the total. Reporting peaked in 2024 at $5,994 and has fallen 60.0% since, to $2,396 in 2025. Among cardiovascular disease clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,677in general payments, 2019–2025

Across 137 payments — averaging $121.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$6K
  • Biotronik Inc.$4K
  • Medtronic$4K
  • Boston Scientific$1K
  • Abiomed$475
  • E.r. Squibb & Sons, L.L.C.$276
  • plus $961 from 11 others

What the payments were for

  • Grants$1,1267%
  • Travel & lodging$8,23449%
  • Food & beverage$6,90741%
  • Education$4102%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,677 in reported general payments places this provider in the 90th percentile of 175 cardiovascular disease providers in Kansas.

See all cardiovascular disease providers in Kansas

Medicare billing

Part B allowed, 2024
$86,121
Medicare patients
207
Services billed
793

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate29$332
Atorvastatin Calcium21$246
Rosuvastatin Calcium13$88
ClopidogrelClopidogrel Bisulfate11$75
Furosemide11$18

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →